Inhibrx Biosciences, Inc. (INBX)
82.21
-2.30
(-2.72%)
USD |
NASDAQ |
Dec 11, 16:00
82.00
-0.21
(-0.26%)
After-Hours: 20:00
Inhibrx Biosciences Shareholders Equity (Quarterly): 36.83M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -274.14M |
| Ligand Pharmaceuticals, Inc. | 950.17M |
| Armata Pharmaceuticals, Inc. | -95.59M |
| Adverum Biotechnologies, Inc. | -55.65M |
| Pelthos Therapeutics, Inc. | 58.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.47M |
| Total Liabilities (Quarterly) | 140.64M |
| Debt to Equity Ratio | 2.903 |
| Current Ratio | 4.486 |
| Net Debt Paydown Yield | -4.30% |